Comparative Studies on the in Vitro Drug Dissolution Profiles for Hydroxyzine Hydrochloride Tablets

Abstract

Spanish

French

OBJECTIVE:

A significant practical problem in the standardization of dissolution testing is addressed. In vitro releasing characteristics of hydroxyzine hydrochloride tablets are presented to further the documentation of bioequivalency criteria.

DESIGN:

The assessment model compares the official United States Pharmacopeia disintegration approach for dissolution analysis with that of the Food and Drug Administration's recommended rotating paddle technique for inducing aqueous disruption of the solid oral dosage form.

RESULTS:

The rationale and significance of the study focuses attention on the variation in release of the active ingredient observed relative to the four formulation strengths. With differences in the extent of dissolution noted and official standards in mind, emphasis is placed on the development of an alternate test protocol.

CONCLUSIONS:

Dissolution data derived via ultraviolet spectrophotometry revealed statistically significant differences in the amount of hydroxyzine hydrochloride being released from its coated structure, the extent of which was found to be dependent on the acid nature of the simulated gastric dissolution medium used and intensity of mixing action employed.

Get full access to this article

View all access options for this article.

References

Tran

. Hydroxyzine hydrochloride. Food & Drug Administration NDA supplement review #10–392; December 15, 1980.

Physicians desk reference. 46th ed. Oradell, NJ: Medical Economics, 1992: 1941.

Huang

Pong

. Comparative studies on distribution, excretion and metabolism of hydroxyzine-3H and its metabolite-14C in rats. Am J Hosp Pharm 1974; 63: 1527–32.

Hydroxyzine hydrochloride. American hospital formulary service. Bethesda, MD: American Society of Hospital Pharmacists, 1992: 1368.

USP XXII-NF XVII preamble/preface. Bethesda, MD: United States Pharmacopeial Convention, 1990: xliii.

USP XXII-NF XVII hydroxyzine hydrochloride. Bethesda, MD: United States Pharmacopeial Convention, 1990: 675.

Tran

. Hydroxyzine hydrochloride. Food & Drug Administration NDA supplement review #10–392; April 18, 1986.

USP XXII-NF XVII disintegration, section 701 and dissolution, section 711. Bethesda, MD: United States Pharmacopeial Convention, 1990: 1577–9.

Dissolution operations manual, model 72. Northridge, CA: Hanson Research Corporation.

10.

USP XXII-NF XVII apparatus suitability test. Bethesda, MD: United States Pharmacopeial Convention, 1990: 1579.

11.

USP XXII-NF XVII uniformity of dosage units, section 905. Bethesda, MD: United States Pharmacopeial Convention, 1990: 1617–9.

12.

Applied statistics—linear regression model ST 1–08. Dallas: Texas Instruments, 1975: 34–7.

13.

Hydroxyzine hydrochloride. In: Florey

, ed. Analytical profiles of drug substances. New York: Academic Press, 1975: 325.

14.

Pharmaceutical forum: proposed USP policy on dissolution standards. Bethesda, MD: United States Pharmacopeial Convention, 1980: 510–1.

15.

Pharmaceutical forum: proposed USP policy on dissolution standards. Bethesda, MD: United States Pharmacopeial Convention, 1981: 1225–7.

16.

Hydroxyzine hydrochloride and hydroxyzine pamoate. Federal Register 1979; 44(Feb 2):6780–4.

17.

PMA, FDA comment on new USP policy. Gold sheets 1981; 15 (3):1–4.

18.

Pernarowski

. Dissolution methodology. In: Leeson

Carstensen

, eds. Dissolution technology. Washington, DC: Academy of Pharmaceutical Sciences, 1974: 64–6.

19.

Handbook of drug dissolution standards. Explanatory notes. Rockville, MD: Division of Biopharmaceutics, Food & Drug Administration, 1985.

20.

Feinhold

. Influence of pH of the dissolution media on rate of dissolution from loose powders, granules and tablets. In: Leeson

Carstensen

, eds. Dissolution technology. Washington, DC: Academy of Pharmaceutical Sciences, 1974: 138–9.

21.

Winer

Brown

Michels

. Statistical principles in experimental design. 3rd edition. New York: McGraw-Hill, 1991: 284–496.